A possible alternate pathway for intravascular thrombosis - Investigation of the circumstantial evidence by microfluidics

Main Article Content

Siddhartha Das
Amlan Barai

Abstract

In light of the literature, in this hypothesis, we aimed to settle up an experimental procedure and possible mechanism for bacteremia induced disseminated intravascular coagulation via QA.Bacteremia resulting in sepsis and disseminated intravascular coagulation (DIC) are known for thrombosis and coagulopathy. DIC, which results in simultaneous activation and consumption of coagulation factors, could be investigated using microfluidics as a tool. Here, we propose the hypothesis that bacteria (e.g. E.coli) mediated DIC results from a collective phenomenon called “quorum acting” (QA). If our hypothesis is true, than the coagulation cascade will be activated before systemic inflammation. To check for QA we propose to perform a hemodynamic experiment where blood is controllably flown over E.coli clusters in a microfluidic device. Further, manipulation of the physical properties (flow rate mimicking condition like venous stasis) and chemical properties (hyperglycaemia as in uncontrolled diabetes mellitus) of blood could be done using microfluidic device to mimic their  etiopathogenesis  and to validate our proposed mechanism that quorum acting mediated DIC occurs rapidly in venous stasis and uncontrolled diabetes mellitus respectively.

Downloads

Download data is not yet available.

Article Details

How to Cite
Das, S. ., & Barai, A. . (2017). A possible alternate pathway for intravascular thrombosis - Investigation of the circumstantial evidence by microfluidics. Medical Science and Discovery, 4(1), 1–11. Retrieved from https://medscidiscovery.com/index.php/msd/article/view/180
Section
Review Article

References

Hall JB, Schmidt GA, Wood LD. Principles of critical care: McGraw-Hill New York; 1992

Torio CM, Andrews RM. National inpatient hospital costs: the most expensive conditions by payer, 2011: statistical brief# 160. 2006

Longo D, Fauci A, Kasper D, Hauser S. Harrison's Principles of Internal Medicine 18th edition: McGraw-Hill Professional; 2011.

Kottke-Marchant K, Pathologists CoA. An Algorithmic Approach to Hemostasis Testing: College of American Pathologists; 2008.

Hall JE. Guyton and Hall textbook of medical physiology: Elsevier Health Sciences; 2010.

Levy M, Fink M, Marshall J, Abraham E, Angus D, Cook D, et al., editors. for the international sepsis definitions conference (2003) 2001 SCCM: ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Intensive Care Med 29: 530–538.

Cecil RLF, Goldman L, Schafer AI. Goldman's Cecil Medicine, Expert Consult Premium Edition--Enhanced Online Features and Print, Single Volume, 24: Goldman's Cecil Medicine: Elsevier Health Sciences; 2012.

Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest Journal. 1992;101(6):1644-55.

Hunter P. Sepsis under siege. EMBO reports. 2006;7(7):667-9.

Semeraro N, Ammollo CT, Semeraro F, Colucci M. Sepsis-associated disseminated intravascular coagulation and thromboembolic disease. Mediterranean journal of hematology and infectious diseases. 2010;2(3).

Dunn DL. Gram-negative bacterial sepsis and sepsis syndrome. The Surgical clinics of North America. 1994;74(3):621-35.

Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Critical care medicine. 2001;29(7):1303-10.

Linde-Zwirble WT, Angus DC. Severe sepsis epidemiology: sampling, selection, and society. Critical Care. 2004;8(4):222.

Walker BR, Colledge NR. Davidson's Principles and Practice of Medicine E-Book: Elsevier Health Sciences; 2013.

Simon F, Scheuerle A, Soell A, Groeger M, McCook O, Radermacher P, et al. 30th International Symposium on Intensive Care and Emergency Medicine. Critical Care. 2010;14(1):P1.

Beekmann S, Diekema D, Chapin K, Doern G. Effects of rapid detection of bloodstream infections on length of hospitalization and hospital charges. Journal of clinical microbiology. 2003;41(7):3119-25.

Kastrup CJ, Boedicker JQ, Pomerantsev AP, Moayeri M, Bian Y, Pompano RR, et al. Spatial localization of bacteria controls coagulation of human blood by'quorum acting'. Nature chemical biology. 2008;4(12):742-50.

Shen F, Pompano RR, Kastrup CJ, Ismagilov RF. Confinement regulates complex biochemical networks: initiation of blood clotting by “diffusion acting”. Biophysical journal. 2009;97(8):2137-45.

Miller MB, Bassler BL. Quorum sensing in bacteria. Annual Reviews in Microbiology. 2001;55(1):165-99.

Judy JW. Microelectromechanical systems (MEMS): fabrication, design and applications. Smart materials and Structures. 2001;10(6):1115.

Thompson LF, Willson CG, Bowden MJ. Introduction to microlithography. 1983.

Anna SL, Bontoux N, Stone HA. Formation of dispersions using “flow focusing” in microchannels. Applied physics letters. 2003;82(3):364-6.

Teh S-Y, Lin R, Hung L-H, Lee AP. Droplet microfluidics. Lab on a Chip. 2008;8(2):198-220.

Takeuchi S, Garstecki P, Weibel DB, Whitesides GM. An Axisymmetric Flow‐Focusing Microfluidic Device. Advanced materials. 2005;17(8):1067-72.

Eun Y-J, Utada AS, Copeland MF, Takeuchi S, Weibel DB. Encapsulating bacteria in agarose microparticles using microfluidics for high-throughput cell analysis and isolation. ACS chemical biology. 2010;6(3):260-6.

Bates SM, Weitz JI. Coagulation assays. Circulation. 2005;112(4):e53-e60.

Wessel AK, Hmelo L, Parsek MR, Whiteley M. Going local: technologies for exploring bacterial microenvironments. Nature Reviews Microbiology. 2013;11(5):337-48.

Mao H, Cremer PS, Manson MD. A sensitive, versatile microfluidic assay for bacterial chemotaxis. Proceedings of the National Academy of Sciences. 2003;100(9):5449-54.

Heit JA, Rooke TW, Silverstein MD, Mohr DN, Lohse CM, Petterson TM, et al. Trends in the incidence of venous stasis syndrome and venous ulcer: a 25-year population-based study. Journal of Vascular Surgery. 2001;33(5):1022-7.

Rayfield EJ, Ault MJ, Keusch GT, Brothers MJ, Nechemias C, Smith H. Infection and diabetes: the case for glucose control. The American journal of medicine. 1982;72(3):439-50.

Joshi N, Caputo GM, Weitekamp MR, Karchmer A. Infections in patients with diabetes mellitus. New England Journal of Medicine. 1999;341(25):1906-12.

Butler SO, Btaiche IF, Alaniz C. Relationship between hyperglycemia and infection in critically ill patients. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 2005;25(7):963-76.

Sadaka F, O'Brien J, Migneron M, Stortz J, Vanston A, Taylor RW. Activated protein C in septic shock: a propensity-matched analysis. Crit Care. 2011;15(2):R89.

Gradwohl-Matis I, Dünser MW. On sepsis, troponin and vasopressin: the bitter truth. Critical Care. 2013;17(5):1002.

Skibsted S, Bhasin MK, Aird WC, Shapiro NI. Bench-to-bedside review: future novel diagnostics for sepsis—a systems biology approach. Crit Care. 2013;17(5):231.

Jyothi P, Basavaraj MC, Basavaraj PV. Bacteriological profile of neonatal septicemia and antibiotic susceptibility pattern of the isolates. Journal of natural science, biology, and medicine. 2013;4(2):306.

Mackman N. Role of tissue factor in hemostasis, thrombosis, and vascular development. Arteriosclerosis, thrombosis, and vascular biology. 2004;24(6):1015-22.

Kastrup CJ, Runyon MK, Lucchetta EM, Price JM, Ismagilov RF. Using chemistry and microfluidics to understand the spatial dynamics of complex biological networks. Accounts of chemical research. 2008;41(4):549-58.

Runyon MK, Johnson-Kerner BL, Kastrup CJ, Van Ha TG, Ismagilov RF. Propagation of blood clotting in the complex biochemical network of hemostasis is described by a simple mechanism. Journal of the American Chemical Society. 2007;129(22):7014-5.

Okorie UM, Denney WS, Chatterjee MS, Neeves KB, Diamond SL. Determination of surface tissue factor thresholds that trigger coagulation at venous and arterial shear rates: amplification of 100 fM circulating tissue factor requires flow. Blood. 2008;111(7):3507-13.

Kastrup CJ, Shen F, Runyon MK, Ismagilov RF. Characterization of the threshold response of initiation of blood clotting to stimulus patch size. Biophysical journal. 2007;93(8):2969-77.

Colace TV, Jobson J, Diamond SL. Relipidated tissue factor linked to collagen surfaces potentiates platelet adhesion and fibrin formation in a microfluidic model of vessel injury. Bioconjugate chemistry. 2011;22(10):2104-9.

Shen F, Kastrup CJ, Ismagilov RF. Using microfluidics to understand the effect of spatial distribution of tissue factor on blood coagulation. Thrombosis research. 2008;122:S27-S30.

http://www.elveflow.com/microfluidic-tutorials/soft-lithography-reviews-and tutorials/introduction-in-soft-lithography/introduction-about-soft-lithography-and-polymer-molding-for-microfluidic/ Last accessed on 28-11-2016

http://www.veinguide.com/blog/288/varicose-veins-vein-valves-and-venous-insufficiency-Last accessed on 28-11-2016

http://www.veinsofhouston.com/venous-insufficiency Last accessed on 28-11-2016